KLK3 and prostate carcinoma: Compared with both organized PSA-screening and current prostate cancer testing (without organized screening but with high rates of PSA testing), the STHLM3 studies have shown that use of the S3M test may decrease both the number of prostate biopsies and over-diagnosis, while maintaining sensitivity to high-grade disease [3, 4].